Science Pool

Evotec achieves programme designation in neuroscience collaboration with Bristol Myers Squibb

Evotec SE announced today that the Company has reached another programme designation within its neuroscience collaboration with Bristol Myers Squibb triggering a payment of US$ 16 m to Evotec. The programme further adds to a fast-growing pipeline in neurodegeneration that also includes EVT8683, which entered clinical development end of 2021.

Read More

Twitter
LinkedIn
Email